(Q40259630)

19 September 2017

Generation and Production of Modified Vaccinia Virus Ankara (MVA) as a Vaccine Vector (English)

1 reference

19 September 2017

0 references

Vaccinia Virus

1 reference

5

Sarah C Gilbert

0 references

author name string

Vincent Pavot

1

1 reference

19 September 2017

Sarah Sebastian

2

1 reference

19 September 2017

Alison V Turner

3

1 reference

19 September 2017

Jake Matthews

4

1 reference

19 September 2017

language of work or name

English

0 references

publication date

1 January 2017

1 reference

Methods in Molecular Biology

19 September 2017

1 reference

19 September 2017

1581

1 reference

19 September 2017

97-119

1 reference

Clinical development of Modified Vaccinia virus Ankara vaccines

19 September 2017

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-6869-5_6

Safety and Immunogenicity of Modified Vaccinia Ankara-Bavarian Nordic Smallpox Vaccine in Vaccinia-Naive and Experienced Human Immunodeficiency Virus-Infected Individuals: An Open-Label, Controlled Clinical Phase II Trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-6869-5_6

Immediate-early expression of a recombinant antigen by modified vaccinia virus ankara breaks the immunodominance of strong vector-specific B8R antigen in acute and memory CD8 T-cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-6869-5_6

Expression and cellular immunogenicity of a transgenic antigen driven by endogenous poxviral early promoters at their authentic loci in MVA

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-6869-5_6

Development of a replication-deficient recombinant vaccinia virus vaccine effective against parainfluenza virus 3 infection in an animal model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-6869-5_6

Effects of DNA structure and homology length on vaccinia virus recombination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-6869-5_6

Vaccinia virus: a tool for research and vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-6869-5_6

Growth and maintenance of chick embryo fibroblasts (CEF).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-6869-5_6

10.1007/978-1-4939-6869-5_6

21 January 2018

Identifiers

DOI

1 reference

19 September 2017

1 reference